Brief: Viva Biotech Says Unit Signs Investment Agreement With Hangzhou Qiantang New Area Management Committee
22/09/2020 13:48
Sept 22 (Reuters) - VIVA Biotech Holdings 1873.HK :
* UNIT SIGNED INVESTMENT AGREEMENT WITH HANGZHOU QIANTANG
NEW AREA
MANAGEMENT COMMITTEE
* VIVA HONG THROUGH PROJECT CO TO CONSTRUCT LABORATORY
FACILITIES
ON PROJECT LAND IN QIANTANG NEW AREA, HANGZHOU
* UNIT COMMITTED TO INVEST RMB700 MILLION AS FIXED ASSET
INVESTMENT INTO PROJECT
Source text for Eikon: urn:newsml:reuters.com:*:nHKS4q5LxV
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical